Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMIPRIL vs RAMUCIRUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMIPRIL vs RAMUCIRUMAB: Safety Overview

Metric RAMIPRIL RAMUCIRUMAB
Total FAERS Reports 33,063 5,357
Deaths Reported 3,786 1,444
Death Rate 11.5% 27.0%
Hospitalizations 17,747 2,066
Average Patient Age 65.4 yrs 63.9 yrs
% Female Patients 53.1% 33.0%
FDA Approval Date Apr 15, 2014 N/A
Manufacturer GSMS, Incorporated Eli Lilly and Company
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription